Edition:2024
Format :60 MP4 + 54 PDF files
File Size:29.31 GB
Comprehensive Updates for State-of-the-Art Care: Evaluation, Diagnosis, Treatment, Procedures and Challenging Cases
Pulmonary and Critical Care Medicine will be held online this year, using live streaming, electronic Q&A, and other remote learning technologies. The 2024 program will be highly interactive, providing opportunities throughout the program to pose questions online to nationally and internationally recognized leaders in their respective areas of pulmonary and critical care medicine.
OVERVIEW
This comprehensive course provides education and updates to optimize your care of patients with:
Sepsis
ARDS
Sarcoidosis
IPF
Bronchiectasis
Cystic fibrosis
Lung nodules
Lung cancer
GERD
Pleural disease
Pneumonia
Tuberculosis
Thromboembolism
Chronic cough
COPD
Asthma
Occupational and environmental lung disease
Interstitial lung disease
Lung transplantation
Neurologic issues in the ICU
Sleep-disordered breathing
Post-acute sequelae of COVID-19
Surgical emergencies
Atypical mycobacterial disease
Pulmonary hypertension
Cardiopulmonary disorders
Complications from cardiac arrest
Hypersensitivity pneumonitis
Acute respiratory failure
REASONS TO ATTEND IN 2024
All sessions are led by master clinicians who deliver information in inspiring and entertaining ways, and provide specific recommendations to incorporate the latest updates into your practice. Education covers:
The most current guidelines for treating sepsis
Evidence-based treatment of ARDS
State of the art in interventional pulmonology
High-flow oxygen therapy for respiratory failure
Updates on biologics in asthma and other lung disease
New concepts in the use of vasopressors in septic shock
New drugs and combinations in pulmonary hypertension
New evidence on sedation, analgesia, and early mobility
Point-of-care pulmonary ultrasound in the intensive care unit
Lung microbiome: emerging implications for lung health
Emerging evidence for targeted temperature management
Evaluating occupational and environmental lung disease
Steroid-sparing agents for interstitial lung disease
Pulmonary embolus: the latest treatment strategies
State-of-the-art management of the critically ill patient
Guidance to conduct end-of-life discussions
Updates in pulmonary pathology
New treatment options in cystic fibrosis
Handling neurologic and surgical emergencies in the medical ICU
New approaches that improve outcomes for patients with unexplained chronic cough
Topics And Speakers:
Sunday, April 28, 2024
Morning Program
7:45 am to 8:00 am
Welcome
David J. Kanarek, MD
8:00 am to 8:40 am
GERD in Pulmonology
David J. Kanarek, MD
8:40 am to 9:20 am
Lung Transplantation 2024: Referral, Patient Selection, Lung Allocation, and COVID
Brian Keller, MD
9:20 am to 10:00 am
New Approaches to the Unexplained Chronic Cough
Kai Saukkonen, MD
10:00 am to 10:10 am
Break
10:10 am to 10:50 am
Occupational and Environmental Lung Disease
David Christiani, MD
10:50 am to 11:30 am
Cystic Fibrosis: Understanding CFTR and New Treatment
Isabel Neuringer, MD
11:30 am to 12:10 pm
Beyond Cystic Fibrosis: Diagnosis and Management of Non-CF Bronchiectasis
Christopher Richards, MD
12:10 pm to 1:10 pm
Q & A Session with Speakers
Drs. Christiani, Kanarek, Keller, Lai, Neuringer, Richards, Saukkonen, and Angela Frank, MD, MPH
1:10 pm to 2:00 pm
Break
Afternoon Program
2:00 pm to 2:40 pm
Pulmonary Pathology: Interstitial Lung Disease
Lida Hariri, MD, PhD
2:40 pm to 3:20 pm
Diagnosis and Management of IPF: When, Why, and How to Use the Newest Drugs
Sydney Montesi, MD
3:20 pm to 4:00 pm
Evolving Concepts in the Diagnosis and Management of Connective Tissue Disease-Associated ILD
Barry Shea, MD
4:00pm to 4:10 pm
Break
4:10 pm to 4:50 pm
Hypersensitivity Pneumonitis: Pigeons, Farmers, and Hot Tubs, Oh My!
Rachel Knipe, MD
4:50 pm to 5:30 pm
Treatment Challenges of Pulmonary Sarcoidosis
Robert Hallowell, MD
5:30 pm to 6:10 pm
Palliative Care in Advanced Lung Disease
Bethany-Rose Daubman, MD
6:10 pm to 7:10 pm
Q & A Session with Speakers
Drs. Daubman, Frank, Hallowell, Hariri, Knipe, Montesi, Shea, and Kathryn Hibbert, MD
Monday, April 29, 2024
Morning Program
8:00 am to 8:40 am
ARDS: State-of-the-Art Strategies to Protect the Lung
Kathryn Hibbert, MD
8:40 am to 9:20 am
Noninvasive Respiratory Support for Acute Respiratory Failure: Less May Not Be Best
Carolyn La Vita, MHA, RRT
9:20 am to 10:00 am
Novel Ventilator Modes: The Hype and Reality
Carolyn La Vita, MHA, RRT
10:00 am to 10:10 am
Break
10:10 am to 10:50 am
Fluid Responsiveness
David Ziehr, MD
10:50 am to 11:30 am
Vasopressors in Septic Shock: Old Friends and New
Jason Griffith, MD, PhD
11:30 am to 12:10 pm
Point-of-Care Pulmonary Ultrasound in the Intensive Care Unit
Jonah Rubin, MD
12:10 pm to 1:10 pm
Q & A with Speakers
Drs. Kanarek, North, Rubin, and Wong, and Carolyn La Vita, MHA, RRT
1:10 pm to 2:00 pm
Afternoon Program
2:00 pm to 2:40 pm
The Legacy of COVID: A Clinical Approach to Post Acute Sequelae of COVID
Leo Ginns, MD
2:40 pm to 3:20 pm
After the ICU: Post-ICU Care Syndrome and Recovery
George Alba, MD
3:20 pm to 4:00 pm
Approach to Empiric Antibiotics in the ICU
Alyssa Letourneau, MD
4:00 pm to 4:10 pm
Break
4:10 pm to 4:50 pm
Approach to the Immunocompromised Critically Ill Patient
Lisa Bebell, MD
4:50 pm to 5:30 pm
Community-Acquired Pneumonia: The Newest Guidelines and State-of-the-Art Treatment Strategies State-of the-Art Treatment Strategies
Joshua Metlay, MD, PhD
5:30pm to 6:10pm
The Microbiome and Lung Disease
Peggy Lai, MD
6:10pm to 7:10pm
Expanded Q & A Session
Drs. Alba, Bebell, Ginns, Hibbert, Lai, Letourneau, and Metlay
Tuesday, April 30, 2024
Morning Program
8:00am to 8:40am
Common Neurologic Issues in the ICU
Sahar Zafar, MD
8:40am to 9:20am
From Ancient Egypt to Balanced Crystalloids: Medicine’s Attempts to Manage Sepsis
Eric Schmidt, MD
9:20 am to 10:00 am
Sedation, Analgesia, and Early Mobility: The State of the Art in 2024
Crystal North, MD, MPH
10:00 am to 10:10 am
Break
10:10 am to 10:50 am
TTM and Neuroprognostication after Cardiac Arrest
David Greer, MD
10:50 am to 11:30 am
Prognosis and Uncertainty in the ICU
Emily Rubin, MD
11:30 am to 12:10 pm
Surgical Emergencies in the Medical ICU
Noelle Saillant, MD
12:10 pm to 1:10 pm
Q & A with Speakers
Drs. Frank, Greer, North, Rubin, Saillant, Schmidt, and Zafar
1:10 pm to 2:00 pm
Break
Afternoon Program
2:00 pm to 2:40 pm
Thrombotic Mechanisms and Antithrombotic Agents: How Do the New Oral Agents Fit in 2024?
Rachel Rosovsky, MD, MPH
2:40 pm to 3:20 pm
Pulmonary Embolism: An Update
Alison Witkin, MD
3:20 pm to 4:00 pm
Pulmonary Hypertension: Categorization and Evaluation
Josanna Rodriguez-Lopez, MD
4:00 pm to 4:10 pm
Break
4:10 pm to 4:50 pm
Pulmonary Hypertension: Management
Alexandra “Sasha” Wong, MD
4:50 pm to 5:30 pm
Vasculitis and ANCA
John Niles, MD
5:30 pm to 6:10 pm
Exercise and Cardiopulmonary Disorders: Indications and Interpretation
Corey Hardin, MD, PhD
6:10 pm to 7:10 pm
Q & A with Speakers
Drs. Hardin, Hibbert, Niles, Rodriguez-Lopez, Rosovsky, Witkin, and Wong
Wednesday, May 1, 2024
Morning Program
8:00 am to 8:40 am
Pleural Disease: 2024 Updates
Fayez Kheir, MD, MSc
8:40 am to 9:20 am
Interventional Pulmonology in 2024
Erik Folch, MD
9:20 am to 10:00 am
Interventional Bronchoscopy in COPD: Valves, Coils, and Beyond
Colleen Keyes, MD, MPH
10:00 am to 11:00 am
Extended Q & A with Interventional Pulmonary Faculty
Drs. Folch, Frank, Keyes, and Kheir
11:00 am to 11:10 am
Break
11:10 am to 11:50 am
Looking Deeper: Patterns and Insights from Chest Radiology
Amita Sharma, MBBS
11:50 am to 12:30 pm
A Strategic Approach to the Management of Pulmonary Nodules
Angela Frank, MD, MPH
12:30 pm to 1:10 pm
Treatment of Non-Small Cell Lung Cancer: Traditional Chemotherapy, Targeted Therapy, and Immunotherapies
Jaime Schneider, MD, PhD
1:10 pm to 2:00 pm
Break
Afternoon Program
2:00 pm to 2:40 pm
COPD 2024
Walter O’Donnell, MD
2:40 pm to 3:20 pm
Asthma: Ensuring Your Treatment Approaches Are Current with the State of the Art
Jehan Alladina, MD
3:20 pm to 4:00 pm
New Therapeutics in Lung Disease: The Age of Immunotherapy
Benjamin Medoff, MD
4:00 pm to 4:10 pm
Break
4:10 pm to 4:50 pm
Aspergillus Lung Disease
Rod Rahimi, MD
4:50 pm to 5:30 pm
Tuberculosis in 2024
Maha Farhat, MD, MSc
5:30 pm to 6:10 pm
Non-Tuberculous Mycobacterial Disease: Navigating the Labyrinth
Rocío Hurtado, MD, DTM&H
6:10 pm to 7:10 pm
Q & A with Speakers
Drs. Alladina, Farhat, Frank, Hibbert, Hurtado, Medoff, Metlay, Montesi, O’Donnell, Schneider, and Sharma
Thursday, May 2, 2024
Morning Program: Sleep Medicine for Pulmonologists
8:00 am to 9:00 am
Obstructive Sleep Apnea
James Mojica, MD, FAASM
9:00 am to 10:00 am
Complex Sleep Apnea 2024
James Mojica, MD, FAASM
10:00am to 10:10am
Break
10:10am to 11:10am
Sleep Diagnostics
Katherine Dudley, MD
11:10am to 12:10pm
Noninvasive Ventilation
Katherine Dudley, MD
12:10pm to 12:25pm
Break
12:25pm to 1:10pm
Q & A Session
Drs. Dudley, Kanarek, and Mojica
